<DOC>
	<DOC>NCT00375713</DOC>
	<brief_summary>Korean double-blind non-inferiority study to asses the efficacy (as measured by the responder rate of pruritus severity score by the patient at visit 4 or end-of-treatment visit over the 2 weeks treatment period) and safety of Xyzal速 to Zyrtec速 in subjects suffering from dermatitis and eczema with pruritus symptoms</brief_summary>
	<brief_title>Randomized Phase III Study to Evaluate the Efficacy and Safety of Xyzal速 (Levocetirizine) vs Zyrtec速 (Cetirizine) in Subjects With Dermatitis and Eczema</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Levocetirizine</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>Subjects diagnosed as having atopic dermatitis, contact dermatitis, prurigo, pruritus in the dermatitis and eczema Subjects who require and agree to the concomitant use of a topical steroid preparation. Subjects having a minimum level of pruritus and having used topical hydrocortisone during the run in period Written informed consent signed and dated by subject/legal guardian Female subjects with childbearing potential are eligible if they use a medically accepted contraceptive method and have a negative pregnancy test. Subjects with a known hypersensitivity to cetirizine or levocetirizine Any clinically significant condition that might interfere with the treatment evaluation, both for efficacy and safety Have used forbidden concomitant medications or having not respected adequate washout periods as defined by the protocol</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Dermatitis</keyword>
	<keyword>Eczema</keyword>
	<keyword>Pruritus</keyword>
	<keyword>Xyzal</keyword>
	<keyword>Zyrtec</keyword>
	<keyword>Levocetirizine</keyword>
	<keyword>Cetirizine</keyword>
</DOC>